Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Asset Utilization Ratio (2016 - 2025)

Vanda Pharmaceuticals' Asset Utilization Ratio history spans 15 years, with the latest figure at 0.4 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 29.79% to 0.4 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.4, a 29.79% increase, with the full-year FY2025 number at 0.38, up 23.86% from a year prior.
  • Asset Utilization Ratio hit 0.4 in Q4 2025 for Vanda Pharmaceuticals, up from 0.35 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for VNDA hit a ceiling of 0.47 in Q1 2021 and a floor of 0.27 in Q1 2024.
  • Historically, Asset Utilization Ratio has averaged 0.37 across 5 years, with a median of 0.38 in 2023.
  • Biggest five-year swings in Asset Utilization Ratio: plummeted 32.0% in 2024 and later rose 29.79% in 2025.
  • Tracing VNDA's Asset Utilization Ratio over 5 years: stood at 0.46 in 2021, then fell by 11.54% to 0.41 in 2022, then dropped by 26.27% to 0.3 in 2023, then grew by 2.29% to 0.31 in 2024, then rose by 29.79% to 0.4 in 2025.
  • Business Quant data shows Asset Utilization Ratio for VNDA at 0.4 in Q4 2025, 0.35 in Q3 2025, and 0.32 in Q2 2025.